---
title: "傳百度副總裁謝廣軍已接管新部門，家人曾涉 “開盒素人” 事件"
description: "百度副總裁謝廣軍已接管業務能效部門，百度未對此人事調整作出回應。謝廣軍女兒曾參與 “開盒素人” 事件，引發爭議，謝廣軍曾公開致歉。百度調查後稱事件信息來自非法社工庫。今年 7 月有傳聞稱謝廣軍將離職，但內部人士表示其信息仍可在公司系統中檢索。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261989554.md"
published_at: "2025-10-21T06:55:52.000Z"
---

# 傳百度副總裁謝廣軍已接管新部門，家人曾涉 “開盒素人” 事件

> 百度副總裁謝廣軍已接管業務能效部門，百度未對此人事調整作出回應。謝廣軍女兒曾參與 “開盒素人” 事件，引發爭議，謝廣軍曾公開致歉。百度調查後稱事件信息來自非法社工庫。今年 7 月有傳聞稱謝廣軍將離職，但內部人士表示其信息仍可在公司系統中檢索。

10 月 21 日下午消息，據報道，百度進行了人事調整，ACG 副總裁謝廣軍接管業務能效部門。截至發稿，百度方面未就上述人事調整回應新浪科技問詢。今年 3 月，謝廣軍女兒被曝參與了 “開盒素人” 事件，引發大量爭議。彼時謝廣軍曾發朋友圈致歉。隨後，百度方面回應稱，經過調查，開盒信息來自海外的社工庫，一個通過非法手段收集個人隱私信息的數據庫。今年 7 月，網傳謝廣軍已提離職，據百度內部人士彼時回應新浪科技，“在公司內部系統中仍可檢索到謝廣軍信息，具體人事變動細節尚未明確”。

### Related Stocks

- [BIDU.US - 百度](https://longbridge.com/zh-HK/quote/BIDU.US.md)
- [09888.HK - 百度-SW](https://longbridge.com/zh-HK/quote/09888.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Alibaba (BABA) Upgrades Qwen AI Model as China's Tech Giants Battle for Users | Alibaba has upgraded its AI model to Qwen3.5, enhancing its capabilities in text, image, and video processing. This move | [Link](https://longbridge.com/zh-HK/news/276055492.md) |
| U.S. Removes List Linking Alibaba, Baidu to China Military | The Pentagon added several Chinese companies, including Alibaba and Baidu, to its Section 1260H list, linking them to Ch | [Link](https://longbridge.com/zh-HK/news/275920712.md) |
| Mendel Money Management Invests $3.14 Million in Quanta Services, Inc. $PWR | Mendel Money Management has invested $3.14 million in Quanta Services, acquiring 7,578 shares, making it the 25th larges | [Link](https://longbridge.com/zh-HK/news/276450676.md) |
| German Defense Ministry Says 'No Concrete Plans' to Purchase More Lockheed Martin F-35 Jets | German Defense Ministry Says 'No Concrete Plans' to Purchase More Lockheed Martin F-35 Jets | [Link](https://longbridge.com/zh-HK/news/276443665.md) |
| What Analysts Are Saying About Bristol-Myers Squibb Stock | 16 analysts have evaluated Bristol-Myers Squibb (NYSE:BMY), revealing mixed sentiments with 4 bullish, 3 somewhat bullis | [Link](https://longbridge.com/zh-HK/news/276477307.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
